Clinical Trials

Title   A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects with Nonalcoholic Steatohepatitis (NASH)
Description   The primary objectives of this study are to evaluate the effect of Obeticholic Acid treatment compared to placebo on 1) histological improvement and 2) liver-related clinical outcomes in patients with non-cirrhotic nonalcoholic steatohepatitis (NASH) with liver fibrosis.
IRB Number   17-072
Treatment   Steatoheptatitis
Status   Active
Principal Name   Phillip Henderson, D.O.
Contact Name   Tonya Beacham

Email Newsletters

Connect With Us